Growth Metrics

CorMedix (CRMD) Total Current Liabilities (2016 - 2025)

CorMedix has reported Total Current Liabilities over the past 15 years, most recently at $174.3 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $174.3 million for Q4 2025, up 414.98% from a year ago — trailing twelve months through Dec 2025 was $174.3 million (up 414.98% YoY), and the annual figure for FY2025 was $174.3 million, up 414.98%.
  • Total Current Liabilities reached $174.3 million in Q4 2025 per CRMD's latest filing, up from $133.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $174.3 million in Q4 2025 and bottomed at $3.0 million in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $7.5 million (2023), compared with a mean of $25.8 million.
  • The largest annual shift saw Total Current Liabilities tumbled 47.46% in 2021 before it soared 623.14% in 2025.
  • Over 5 years, Total Current Liabilities stood at $5.3 million in 2021, then grew by 18.07% to $6.3 million in 2022, then surged by 80.65% to $11.4 million in 2023, then skyrocketed by 196.83% to $33.8 million in 2024, then soared by 414.98% to $174.3 million in 2025.
  • Business Quant data shows Total Current Liabilities for CRMD at $174.3 million in Q4 2025, $133.6 million in Q3 2025, and $31.7 million in Q2 2025.